Skip to main content

Market Overview

MediciNova (NASDAQ:MNOV) Press Releases

Tuesday, June 22, 2021

Thinking about buying stock in Torchlight Energy, Globalstar, MediciNova, Senseonics, or Clean Energy Fuels? (CLNE, GSAT, MNOV, SENS, TRCH, Opinion, Press Releases / Tue, 10:50am)

Monday, June 21, 2021

Thinking about buying stock in MediciNova, Torchlight Energy, Atossa Therapeutics, Globus Maritime, or ContextLogic? (ATOS, GLBS, MNOV, TRCH, WISH, Opinion, Press Releases / Mon, 09:31am)
MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature's Translational Psychiatry Journal (MNOV, Health Care, Press Releases, General / Mon, 06:30am)

Monday, June 14, 2021

MediciNova to Participate in Maxim Group LLC Fireside Chat (MNOV, News, Press Releases / Mon, 06:30am)

Monday, June 07, 2021

MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury (MNOV, Press Releases / Mon, 06:30am)

Thursday, May 13, 2021

MediciNova Reports First Quarter 2021 Financial Results and Business Update (Earnings, MNOV, Press Releases / Thu, 04:30pm)

Wednesday, May 05, 2021

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe (MNOV, Health Care, Press Releases / Wed, 08:00pm)

Thursday, April 22, 2021

MediciNova Receives Gene Therapy Milestone Payments (MNOV, News, Press Releases / Thu, 06:30am)

Monday, April 19, 2021

MediciNova to Participate in the B. Riley Neuroscience Conference (MNOV, Press Releases / Mon, 06:30am)

Thursday, April 15, 2021

MediciNova to Participate in the UBS Global Healthcare Virtual Conference (MNOV, News, Press Releases / Thu, 06:30am)

Tuesday, March 09, 2021

MediciNova Announces Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury (MNOV, Health Care, Press Releases, General / Tue, 05:00pm)

Monday, March 08, 2021

MediciNova to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference (MNOV, News, Press Releases / Mon, 07:30am)

Wednesday, March 03, 2021

MediciNova Announces Update on SARS-CoV-2 Vaccine for COVID-19 (MNOV, Health Care, Press Releases / Wed, 07:30am)

Sunday, January 31, 2021

MediciNova Announces Closing of US$20 Million Private Placement Transaction (MNOV, Press Releases / Sun, 07:00pm)

Monday, January 18, 2021

MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan (MNOV, News, Health Care, Legal, Press Releases / Mon, 07:00pm)

Monday, January 11, 2021

MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners (MNOV, News, Financing, Press Releases / Mon, 10:30pm)

Tuesday, December 29, 2020

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS (MNOV, Press Releases / Tue, 07:30am)

Tuesday, December 15, 2020

MediciNova Added to the NASDAQ Biotechnology Index (IBB, MNOV, NBI, Press Releases / Tue, 07:30am)

Wednesday, November 25, 2020

MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published in Multiple Sclerosis Journal (MNOV, Health Care, Press Releases, General / Wed, 07:30am)

Tuesday, November 24, 2020

MediciNova Announces Initiation of Master Virus Seed Stock Production for its Intranasal COVID-19 Vaccine using BC-PIV Vector Technology (MNOV, Press Releases / Tue, 07:30am)

Thursday, November 12, 2020

MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020 (MNOV, Press Releases, General / Thu, 11:00pm)

Thursday, October 22, 2020

MediciNova, in Collaboration with the University of Sydney and the Australasian Gastro-Intestinal Trials Group, Announces Plans for a Multi-center, Phase 2b Study to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy (MNOV, Press Releases / Thu, 06:30am)

Wednesday, October 21, 2020

MediciNova Appoints Carolyn Beaver to its Board of Directors and as Audit Committee Chair (MNOV, Press Releases / Wed, 06:30am)

Tuesday, October 13, 2020

MediciNova Announces Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model to be Presented at The Liver Meeting Digital Experience™ 2020 (MNOV, Health Care, Press Releases / Tue, 06:30am)

Thursday, September 24, 2020

MediciNova Announces Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology (MNOV, Press Releases / Thu, 06:30am)

Wednesday, September 23, 2020

Friday, September 11, 2020

MediciNova Announces that BioComo's Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology (MNOV, Health Care, Press Releases / Fri, 06:30am)

Tuesday, September 01, 2020

MediciNova Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19 (MNOV, Health Care, Press Releases / Tue, 06:30am)

Thursday, August 06, 2020

Tuesday, August 04, 2020

MediciNova to Participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference (MNOV, News, Press Releases / Tue, 06:30am)

Tuesday, July 28, 2020

Researchers Identify Potent Infection-Blocking Antibodies In Race For COVID-19 Vaccine (AMPE, INO, MNOV, NBIO, OPK, Opinion, Press Releases / Tue, 08:45am)

Monday, July 27, 2020

MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan (MNOV, Press Releases / Mon, 06:30am)

Monday, July 20, 2020

MediciNova to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit (MNOV, News, Health Care, Press Releases / Mon, 06:30am)

Wednesday, July 01, 2020

MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19 (MNOV, Press Releases / Wed, 06:30am)

1	SCR, SEAC: 26 Stocks Moving in Wednesday's Pre-Market Session
2	RAD: Why Rite Aid Stock Is Trading Lower Today
3	TSEM, RETO: 25 Stocks Moving in Thursday's Pre-Market Session
4	BABA: Analyzing Alibaba Group Holding's Unusual Options...
5	LMT, TSLA: Elon Musk Says Will Do His 'Best' T...
6	WGO, INFO: 5 Stocks To Watch For June 23, 2021
7	BABA: Unusual Options Activity Insight...

1	TWTR, $DOGE: 'Pay Me In Dogecoin' Trends On US Twitter As Backers Look T...
2	XPEV, NIO: Nio Named Most Promising Brand For Growth In China Survey
3	ARKG, BFLY: Cathie Wood Loads Up On Quantum-Si For 6th Straigh...
4	VA Rejects New Cannabis Research Bill For Veterans...
5	Leafly Scores Legal Cannabis Markets On Social Jus...
6	PCRFY, TSLA: Tesla Battery Supplier Panasonic Cuts E...
7	TSLA, TWTR: Dogecoin Strikes Major Gains...